Background {#Sec1}
==========

Evidence suggests a positive association between ambient air pollution and risk of type 2 diabetes (T2D) \[[@CR1]--[@CR3]\]. This association is hypothesized to be mediated through inflammatory mechanisms. Experimental evidence \[[@CR4], [@CR5]\] suggests subclinical systemic inflammation occurring at several sites including adipose tissue, liver, skeletal muscles and the autonomic nervous system, with resultant insulin resistance, the hallmark of T2D. On the population level, acute and long-term exposure to ambient air pollution has been linked to raised markers of inflammation including circulating C-reactive proteins (CRP) \[[@CR6], [@CR7]\] IL-6, \[[@CR8]\] fibrinogen \[[@CR9], [@CR10]\] vascular and intracellular adhesion molecules \[[@CR11]\]. Indeed, air pollution is thought to accelerate pro-thrombotic state following lung inflammation through an IL-6 dependent pathway \[[@CR12], [@CR13]\]. Exposure to industrial particulate matter has been shown to induce IL-6 genes in human airway epithelial cells \[[@CR14]\]. Likewise, exposure of mice to particulate matter induced the expression of genes involved in inflammation, lipid metabolism and atherosclerosis \[[@CR8]\].

IL-6 in itself may be related to the development of type 2 diabetes \[[@CR15]\]. Elevated levels of IL-6 were associated with higher incidence of type 2 diabetes \[[@CR16], [@CR17]\], and animal studies also showed IL-6 to inhibit insulin secretion from islet cells following glucose stimulation \[[@CR18]\]. Other in vitro studies also showed negative impacts of IL-6 on insulin sensitivity through reduced insulin receptor expression \[[@CR19]\] and adiponectin gene expression \[[@CR20]\] in adipocytes. Among T2D patients, IL-6 was associated with whole-body insulin resistance and hyperglycemia \[[@CR21]\]. Raised IL-6 levels were also associated with hyperinsulinemia in patients without T2D \[[@CR22]\].

*IL6* gene plays an important role in the regulation of systemic inflammatory pathways. Some common single nucleotide polymorphisms (SNPs), including *IL6* -572G \> C and *IL6* -174G \> C have been shown to influence the levels of circulatory IL-6 \[[@CR23], [@CR24]\], as well as circulating CRP \[[@CR25]\]. In these studies, the major G alleles of both variants were identified as the pro-inflammatory alleles. Recent meta-analyses of 11,681 individuals of Asian and European descent showed the G allele of *IL6* -572G \> C to be associated with increased risk of T2D \[[@CR26]\] whereas another study of 22,626 individuals of European descent showed the C allele of *IL6* -174G \> C to be associated with decreased risk of T2D \[[@CR27]\].

Studying gene-environment interactions helps to better understand aetiologic mechanisms and causality of exogenous factors, in this case, air pollution, and to identify population at increased risk of adverse health effects of environmental exposures. We hypothesize, based on the above evidence, that the common functional SNPs, *IL6* -572G \> C and *IL6* -174G \> C, may modify the existing association between air pollutants and diabetes \[[@CR28]\].

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

We studied participants of the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA). This study has been described elsewhere in detail \[[@CR29]\]. Briefly, it consists of a population-based sample of 9651 adults, aged 18--60 when they were recruited at baseline (1990/1991) from eight communities reflecting the diverse geographic and climatic features of Switzerland. Participants underwent health interviews and physical examinations. At first follow-up (2001/2002) which additionally included blood marker and genetic assays, 8047 participants completed at least the screening questionnaire \[[@CR30]\]. 6212 participants at first follow-up, consenting to genetic assays were genotyped for *IL6* -572G \> C and *IL6* -174G \> C in those studies. For the present analysis, we studied 4410 follow-up participants, aged 29--73 years, with complete data on diabetes status, selected covariates, and population stratification data from genome-wide association studies. The algorithm for participant selection is shown on Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Algorithm for participant inclusion in the present study

Participants provided informed consent for participation in the health interviews, physical examinations, blood marker and genetic assays. Ethical clearance for the SAPALDIA study was obtained from the Swiss Academy of Medical Sciences, the National Ethics Committee for Clinical research (UREK, Project Approval Number 123/00) and the Ethics Committees of the eight participating communities including Basel, Wald, Davos, Lugano, Montana, Payerne, Aarau and Geneva.

Identification of diabetes cases {#Sec4}
--------------------------------

Participants were identified as having diabetes if they 1) reported physician diagnosed diabetes or 2) use of diabetes medication in the past month or 3) had non-fasting blood glucose \>11.1 mmol/L or 4) HbA1c \>0.065. Non-fasting blood glucose was measured in all participants whereas HbA1c was only measured if non-fasting glucose \>6.1 mmol/L \[[@CR28]\]. The lack of data on diabetes status at baseline precluded the study of incident diabetes. Also, we could not exclude type 1 diabetes (T1D) and have assumed the majority of these cases to be T2D considering that on the average, \>90 % of adult diabetes are T2D \[[@CR31]\].

Individual assignment of air pollution exposure {#Sec5}
-----------------------------------------------

We considered 10-year means of PM~10~ (particulate matter \<10um in diameter) as our pollutant exposure measure of interest. In our previous studies on diabetes \[[@CR2]\] and metabolic syndrome \[[@CR32]\], associations with nitrogen dioxide (NO~2~) disappeared in two-pollutant models that included NO~2~ and PM~10~, whereas those of PM~10~ remained unchanged. Therefore we did not consider NO~2~ in this study. Estimates of PM~10~ exposure were assigned to participants' residential addresses using dispersion models for the years 1990 and 2000 (respective years before baseline and follow-up) \[[@CR33]\]. This model incorporated data from meteorology, topography and several emission inventories including industrial, agricultural, heavy equipment and traffic at a resolution of 200 × 200 m \[[@CR34]\]. Annual PM~10~ levels measured at fixed monitoring stations across Switzerland and participants' residential histories were further used to derive estimates of mean PM~10~ exposure at participants' residential addresses over the 10-year period preceding the first follow-up health examination \[[@CR28]\].

Genotyping of candidate SNPs, *IL6* -572G \> C and *IL6* -174G \> C.

Genomic DNA was extracted from ethylenediaminetetraacetic acid (EDTA)-buffered whole blood using PUREGENE DNA Purification Kit (GENTRA Systems, Minneapolis, USA) \[[@CR30]\]. Genotyping for these polymorphisms was done using 5'-nuclease fluorescent polymerase chain reaction (Taqman) assay (Applera Europe, Rotkreuz, Switzerland). Detection of end-points was done using a 7000 ABI System detection device (ABI, Rotkreuz, Switzerland) \[[@CR35]\]. Genotyping call rate was \>97.5 %. A random selection of 638 samples (10 %) was genotyped twice for quality control and repeated genotypes were 100 % concordant (R^2^ = 1; *P* \< 0.001). Subsamples of 3015 and 1612 SAPALDIA participants had whole genome genotyping using the Illumina HumanOmniExomeExpress BeadChip and Illumina 610 K quad BeadChip (Illumina, San Diego, CA, USA) respectively. In this combined SAPALDIA subsample which are predominantly of Caucasian ancestry, we derived ten population stratification components using multidimensional scaling analysis (Plink v1.07 \[[@CR36]\]) on 72,122 SNPs with MAF \> 1 % and genotyping call rate \>97 %, present on both genotyping arrays.

Potential confounders {#Sec6}
---------------------

We considered the following characteristics, based on our previous publication on air pollution and diabetes \[[@CR28]\], as potential confounders: age (years; continuous), sex, years of formal education (≤9; \>9), neighbourhood socio-economic index developed from a principal component analysis including occupation and educational level of household head, median rent and number of persons living in a household, expressed as a percentage \[[@CR37]\]. We also considered smoking history (current, former and never smoker; and smoked pack-years computed by multiplying number of cigarette packs per year and number of smoking years), exposure to passive smoke (yes/no), occupational exposure to vapours gases, dusts and fumes (yes/no) daily consumption of at least one portion of fruits and vegetables (never; ≤3 days/week; \>3 days/week respectively). We also considered alcohol consumption (including beers, wines, spirits and liquors: never; ≤1glass/day; \>1glass/day); hours per week of vigorous physical activity defined as taking part in activities that make one sweat or out of breath (\<0.5; ≥0.5), body mass index (BMI; kg/m^2^, continuous) and genome-wide population stratification components.

Statistical analyses {#Sec7}
--------------------

We assessed linkage disequilibrium between *IL6* -572G \> C and *IL6* -174G \> C and tested both candidate SNPs for Hardy-Weinberg equilibrium (HWE) among the genotyped participants regardless of inclusion in the study. We computed an *IL6* genetic risk score (IRS) by summing up the risk alleles (number of G alleles coded as 0, 1 and 2) across both SNPs. We summarized the characteristics of 4410 included participants based on their genotype and also by inclusion and exclusion status. We applied a mixed logistic regression model, with a random intercept by study area to explore the associations of diabetes with both SNPs, IRS and with PM~10~. We generated interaction terms between PM~10~ and candidate SNPs (including IRS) and assessed their associations with prevalent diabetes. Interaction analyses with candidate SNPs involved additive, recessive and co-dominant models. Stratifying by genotype, we assessed the associations between PM~10~ and diabetes, to identify genotype-specific associations. We also stratified by groups of IRS indicating increased inflammatory risk. Since this study included 46 % of baseline participants which differed in several sociodemographic characteristics (Additional file [1](#MOESM1){ref-type="media"}: Table S1), we assessed the effect of potential participant selection bias on our results using inverse probability weighting by applying the inverse of the probability of participating in present study derived at baseline (using variables that significantly predicted participation in the present study), to the primary model in this study. All analyses were performed using a primary model which included, after stepwise selection, participants' age, sex, educational attainment, neighbourhood socio-economic index, smoking status, smoked pack-years, exposure to passive smoke, occupational exposure to vapours, gases, dusts and fumes, consumption of fruits and vegetables, vigorous physical activity, BMI and genome-wide population stratification components and applying a random intercept by study area.

We performed several sensitivity analyses. We defined diabetes based on each of the diagnostic criteria (excluding the cases identified only by alternative criteria). We repeated the interaction analyses using mixed logistic regression models with random slopes by study area to explore if study area influenced any of the observed interactions. All statistical analyses were performed with STATA software, version 14 (Stata Corporation, Texas).

Results {#Sec8}
=======

There were 252 diabetes cases in this study. Mean exposure to PM~10~ was 22.6ug/m^3^ and mean IRS was 3 risk alleles. *IL6* -572G \> C and *IL6* -174G \> C were not in linkage disequilibrium (R^2^ = 0.02; D' = 1.0). The results of the HWE test for *IL6* -572G \> C and *IL6* -174G \> C, which have respective minor allele frequency of 7 and 39 % in the SAPALDIA population are shown in Table [1](#Tab1){ref-type="table"}. *IL6* -174G \> C was in HWE in both cases and controls whereas *IL6* -572G \> C only reached HWE among the diabetes cases (*P* = 0.636) and not among those without diabetes (*P* = 0.006). The overall HWE test for *IL6* -174G \> C and *IL6* -572G \> C was 0.408 and 0.006 respectively (Table [1](#Tab1){ref-type="table"}). In the European study of \~6000 participants reporting an association between *IL6* -572G \> C and T2D, this functional SNP (having MAF = 5 %) was also not in HWE \[[@CR38]\]. Since only 30 participants carry the minor CC genotype of *IL6* -572G \> C, we present the results for this SNP as GG vs. GC + CC, which yields better statistical power.Table 1Distribution of *IL6* -572 G \> C and *IL6* -174 G \> C genotypes and alleles by diabetes statusGenotypeDiabetesNo diabetes*N* = 286*N* = 5554*IL6* -572 G \> C^\*^Genotype GG248 (86.7)4896 (88.2) GC36 (12.6)623 (11.2) CC2 (0.7)35 (0.6)Allele G532 (93)10415 (93.7) C40 (7)693 (6.3)*IL6* -174 G \> C^\*\*^Genotype GG111 (39)2081 (37) GC135 (47)2614 (47) CC40 (14)865 (16)Allele G357 (62)6776 (61) C215 (38)4344 (39)Data are presented as absolute numbers (N) and relative numbers (%) in parentheses^\*^ *P*-value for Hardy-Weinberg Equilibrium (HWE) test in diabetes cases = 0.585; no diabetes = 0.006; overall = 0.006. *P*-value for Fisher's exact test = 0.664^\*\*^ *P*-value for Hardy-Weinberg Equilibrium test in diabetes cases = 0.918; no diabetes = 0.352; overall = 0.408. *P*-value of Chi-square test = 0.762

Compared to the carriers of the major GG genotype, carriers of the GC + CC genotype of *IL6*-572G \> C had higher body mass index and PM~10~ exposure whereas carriers of CC genotype of *IL6* -174G \> C smoked more, consumed more alcohol and had lower exposure to PM~10~ and there was a significant difference in genotype distribution across areas (Table [2](#Tab2){ref-type="table"}). There was no significant difference in diabetes prevalence across genotypes for both polymorphisms (Table [2](#Tab2){ref-type="table"}). Additional file [1](#MOESM1){ref-type="media"}: Table S1 shows the differences in these characteristics between the included and excluded participants. There were significant differences in most of the participants' characteristics including diabetes prevalence and PM~10~ exposure, but the prevalence of these characteristics were generally higher among the included participants compared to the excluded ones (Additional file [1](#MOESM1){ref-type="media"}: Table S1). The *IL6* -572G \> C and *IL6* -174G \> C genotypes, and IRS were similarly distributed between both groups (Additional file [1](#MOESM1){ref-type="media"}: Table S1).Table 2Characteristics of participants by *IL6* -572 G \> C and *IL6* -174 G \> C genotypes*IL6* -572 G \> C*IL6* -174 G \> CGG (*N* = 3891)GC + CC (*N* = 519)*P* (Chi^2^)GG (*N* = 1618)GC (*N* = 2110)CC (*N* = 682)*P* (Chi^2^)Proportion (%)Females48.449.10.76848.348.150.60.509Education ≥9 years94.993.20.10794.494.995.00.721Never-smokers44.345.60.49042.444.848.10.036Passive smoke exposure46.446.60.92748.645.444.40.078Occupational VGDF exposure42.842.40.84543.942.640.90.398Alcohol intake ≤1glass/day91.091.40.62089.891.293.00.050Alcohol intake \>1glass/day9.09.610.28.87.0Portion of raw vegetables ≤3 days/week18.220.80.15017.419.119.40.351Portion of raw vegetables \>3 days/week81.879.282.680.980.6Portion of fruits ≤3 days/week35.835.60.92335.036.236.70.657Portion of fruits \>3 days/week64.264.465.063.863.3Portion of citrus fruits ≤3 days/week64.264.00.90964.263.964.80.917Portion of citrus fruits \>3 days/week35.836.035.836.135.2Vigorous physical activity \<0.5 h/week35.537.20.44937.334.634.20.082Vigorous physical activity ≥0.5 h/week64.562.862.165.465.8Diabetes cases5.56.70.2606.25.54.80.430Areas: Basel11.512.90.06210.511.614.8\<0.001 Wald19.119.119.018.620.8 Davos7.76.97.57.97.0 Lugano12.614.615.012.68.4 Montana11.16.99.211.212.0 Payerne13.112.713.312.115.2 Aarau16.619.316.917.614.4 Geneva8.47.58.68.47.3Means (SD)*T*-testANOVAAge (years)51.8 (11)51.3 (11)0.26951.8 (11)51.8 (11)51.5 (11)0.732BMI (kg/m^2^)25.8 (4.3)26.3 (4.3)0.02526.0 (4.3)25.8 (4.3)25.9 (4.3)0.152Neighborhood SEI63.7 (10)63.8 (10)0.82763.5 (10)63.9 (10)63.8 (9)0.45510-year mean PM~10~ (μg/m^3^)21.8 (7.3)22.8 (7.2)0.00522.3 (7.4)21.9 (7.3)21.5 (6.9)0.030Pack-years of smoking^a^0 (14)0.1 (16)0.2960.3 (16)0 (16)0 (14)0.524VGDF: vapours, gases, dusts and fumes; SD: standard deviation; BMI: body mass index; SEI: socio-economic index; PM~10~: particulate matter \<10 μm in diameter. ^a^values represent median (interquartile range) and *P*-values represent significance level of median test

The positive association between air pollutants and diabetes, which we previously observed in our previous study of 6392 participants at this follow-up study \[[@CR28]\], persisted in the present sample. The adjusted odds of diabetes increased by 47 % (95 % CI: 1.21, 1.78) per 10ug/m^3^ of exposure to PM~10~. We did not observe any significant association between the candidate *IL6* SNPs and diabetes, across three genetic models. We also did not observe significant associations between IRS and diabetes in our sample (Additional file [1](#MOESM1){ref-type="media"}: Table S2).

Stratified by genotypes, the association between PM~10~ and diabetes was most pronounced among carriers of the major GG pro-inflammatory alleles for both polymorphisms (Fig. [2](#Fig2){ref-type="fig"}). We observed significant interactions between PM~10~ and *IL6* -572G \> C in the additive and recessive models which became more significant in the models accounting for potential selection bias by IPW and remained significant following Bonferroni correction at *P* = 0.01 (0.05/5) (Table [3](#Tab3){ref-type="table"}). We did not observe any statistically significant interactions with *IL6* -174G \> C across genetic models and adjustment for potential selection bias by IPW (Table [3](#Tab3){ref-type="table"}). We observed a positive trend in the association between PM~10~ and diabetes across levels of IRS (Fig. [2](#Fig2){ref-type="fig"}). Carriers of four pro-inflammatory G alleles had the highest odds of diabetes per 10ug/m^3^ increase in exposure to PM~10~ (*P*~interaction~ = 0.10) (Fig. [2](#Fig2){ref-type="fig"}). Compared to carriers of two pro-inflammatory G alleles, carriers of four risk alleles had 60 % (95 % CI: −15 %, 197 %) higher odds of diabetes per 10ug/m^3^ increase in exposure to PM~10~. These interactions were largely stable to confounder adjustments.Fig. 2Interaction between PM~10~ and *IL6* polymorphisms on odds of diabetes. Odds ratio values represent percentage increase of odds of diabetes per 10 μg/m^3^ increase in PM~10~ exposure adjusted for potential selection bias. PM~10~: particulate matter \<10 μm in diameter. All associations are adjusted for body mass index, age, sex, socio-economic status, smoking habits, consumption of alcohol, fruits and vegetables, physical activity and genome-wide population stratification. Study area was treated as a random effect in all modelsTable 3Associations and interactions between PM~10~ and candidate SNPs on odds of diabetes, applying inverse probability weighting (IPW) to account for potential selection biasGenotypeGenotype-specific PM~10~ and diabetes association OR (95 % CI)*P*-value^\*^*P*-value of interaction^\*\*^*P*-value of interaction^\*\*\*^*P*-value of interaction^\*\*\*\*^*IL6* -572G \> CAdjusted model without IPW GG1.53 (1.22, 1.92)\<0.0010.031*n.d.*0.058 GC + CC0.87 (0.51, 1.49)0.618Adjusted model applying IPW GG1.53 (1.23, 1.91)\<0.0010.003*n.d.*0.006 GC + CC0.74 (0.46, 1.20)0.225*IL6* -174G \> CAdjusted model without IPW GG1.49 (1.09, 2.04)0.0120.7630.9660.645 GC1.35 (1.01, 1.80)0.046 CC1.43 (0.80, 2.54)0.226Adjusted model applying IPW GG1.44 (1.07, 1.93)0.0160.8470.9550.749 GC1.34 (1.01, 1.78)0.044 CC1.41 (0.76, 2.61)0.226Adjusted models include age, sex, educational attainment, neighborhood-level socio-economic status, smoking status, pack-years of smoking, exposure to passive smoke and occupational dusts and fumes, dietary fibre intake, alcohol consumption, physical activity, body mass index (BMI), PM~10~. Study area was treated as random effects in all models. OR: odds ratio; CI: confidence intervals; OR values represent percent increase in odds of diabetes per 10 μg/m^3^ increase in PM~10~ exposure. PM~10~: particulate matter \<10 μm in diameter.^\*^ *P*-value of genotype specific association between PM~10~ and diabetes.^\*\*^ additive model (per G allele); ^\*\*\*^dominant model (GG + GC vs. CC); ^\*\*\*\*^recessive model (GG vs. GC + CC); *n.d.*: not done due to the few number of CC allele carriers

Sensitivity analyses showed very similar results. Defining diabetes according to each of the classification criteria showed very similar results with significant interactions in the additive and recessive genetic models (Table [4](#Tab4){ref-type="table"}). Odds of diabetes identified through blood tests among GG genotype carriers remained positive but less significant (Table [4](#Tab4){ref-type="table"}). Applying a logistic regression model with random slopes by study area also did not change estimates of the interaction between PM~10~ and the candidate SNPs on prevalent diabetes, but changed the estimated association between PM~10~ and diabetes among the pro-inflammatory GG genotype carriers (Table [4](#Tab4){ref-type="table"}). In a sub-sample of 2825 non-asthmatic participants who were genotyped using the Illumina Human Omni Exome Express Bead Chip, where *IL6* -572G \> C was in HWE (Pearson's correlation R^2^ between both SNPs =1), associations persisted among pro-inflammatory GG carriers \[OR: 1.64 (1.24, 2.16)\] and interactions persisted in the models accounting for potential selection bias (*P*~(additive)~ =0.053; *P*~(recessive)=~ 0.048).Table 4Other Sensitivity AnalysesSensitivity analysisGenotypeAdjusted OR (95 % CI)*P*-value^\*^*P*-value^\*\*^*P*-value^\*\*\*^*P*-value^\*\*\*\*^Diabetes defined as self-reported physician diagnosis and medication use \[N(diabetes) = 196\]*IL6* -572G \> CGG1.41 (1.11, 1.79)0.0050.001*n.d.*0.004GC + CC0.63 (0.38, 1.04)0.070*IL6* -174G \> CGG1.23 (0.88, 1.71)0.2220.9310.7970.794GC1.33 (0.98, 1.81)0.065CC1.17 (0.58, 2.35)0.669Diabetes defined as self-reported physician diagnosis only \[N(diabetes) =193\]*IL6* -572G \> CGG1.43 (1.13, 1.83)0.0030.008*n.d.*0.003GC + CC0.63 (0.38, 1.04)0.072*IL6* -174G \> CGG1.23 (0.88, 1.71)0.2260.8810.7490.694GC1.38 (1.01, 1.88)0.041CC1.16 (0.57, 2.33)0.680Diabetes defined as self-reported use of diabetes medication only \[N(diabetes) =125\]*IL6* -572G \> CGG1.25 (0.95, 1.66)0.1130.008*n.d.*0.031GC + CC0.49 (0.22, 1.10)0.085*IL6* -174G \> CGG1.10 (0.72, 1.66)0.6660.9540.6000.803GC1.24 (0.86, 1.78)0.246CC0.90 (0.36, 2.28)0.829Diabetes cases identified from blood tests only \[N (diabetes) = 184\]*IL6* -572G \> CGG1.65 (1.27, 2.13)\<0.0010.002*n.d.*0.006GC + CC0.70 (0.39, 1.25)0.223*IL6* -174G \> CGG1.46 (1.04, 2.06)0.0300.7380.5530.962GC1.41 (1.00, 1.99)0.052CC1.83 (0.86, 3.90)0.118Model applying random slopes for study areas \[N(diabetes) = 252\]*IL6* -572G \> CGG0.92 (0.44, 1.92)0.8190.004*n.d.*0.008GC + CC0.44 (0.19, 1.05)0.065*IL6* -174G \> CGG0.86 (0.41, 1.83)0.7040.8140.9280.687GC0.78 (0.36, 1.70)0.540CC0.85 (0.33, 2.20)0.735Adjusted models include age, sex, educational attainment, neighborhood-level socio-economic status, smoking status, pack-years of smoking, exposure to passive smoke and occupational dusts and fumes, dietary fibre intake, alcohol consumption, physical activity, body mass index (BMI), PM~10~. Study area was treated as random effects in all models except the model with random slopes for study area.OR: odds ratio; CI: confidence intervals; OR values represent percent increase in odds of diabetes per 10 μg/m3 increase in PM~10~ exposure. PM~10~: particulate matter \<10 μm in diameter; *n.d*: not done due to very low sample size for CCgenotype. ^\*^ *P*-value of genotype specific association between air pollutant and diabetes. ^\*\*^additive model (per C allele); ^\*\*\*^dominant model (GG + GC vs. CC); ^\*\*\*\*^recessive model (GC + CC vs.GG)

Discussion {#Sec9}
==========

We found a modifying effect of *IL6* -572G \> C polymorphism on the association between air pollutants and diabetes, where carriers of the pro-inflammatory GG genotype were most susceptible. These associations were highly stable to confounder adjustments and remained robust across several sensitivity analyses. The lack of interaction with *IL6* -174G \> C is supported by the fact that both SNPs are not in linkage disequilibrium. Combining both SNPs into an IRS showed increased association among participants at high genetic risk of inflammation.

The lack of association between PM~10~ and DM among the GG genotype carriers in the fixed effect model could be attributed to variation of PM~10~ constituents across different areas (Pearson's R for PM~10~ crustal components across four SAPALDIA areas = 0.34) \[[@CR39]\]. Due to the fact that the likelihood-ratio tests for interactions between PM~10~ and study area (also between SNP and study area) were non-significant (*P* \> 0.2), and that the goal of SAPALDIA air pollution studies is to capture the between area differences in health effects which cannot be explained by the fixed factors in the models, we performed the main analyses using area as a random covariate. In addition, applying the fixed effects model did not change our estimates of interaction between *IL6* polymorphisms and PM~10~ which is our main interest in this study. The reduced significance of interactions among those reporting the use of diabetes medication is most likely to be due to under-reporting of medication use. The absence of any significant association between the *IL6* polymorphisms and diabetes in our sample may be due to our inability to differentiate T1D from T2D, or the relatively small number of cases compared to other studies \[[@CR26]\]. Thus, our observation of a significant interaction is surprising given the limited number of cases in our study.

To our knowledge, this is the first evidence on gene-air pollution interaction in adult diabetes. Until now, gene-air pollution interaction studies focused on respiratory and cardiovascular outcomes, exploring diverse candidate genes or polymorphisms, pollutants and outcomes \[[@CR40]--[@CR42]\]. Many of the interacting genes including *IL6*, regulate systemic oxidative stress and inflammatory pathways \[[@CR41], [@CR43]\]. *IL6* is one of the genes involved in systemic inflammation by regulating or inducing the production of inflammatory cytokines such as IL-6 and CRP. In-vitro studies also show that exposure to particulate matter induces *IL6* and *CRP* gene expression in epithelial and macrophage cell lines \[[@CR14], [@CR44], [@CR45]\]. In addition, polymorphisms on *IL6* have been shown to interact with acute exposure to carbon monoxide and nitrogen dioxide, in eliciting plasma IL-6 response \[[@CR43]\].

Our results support the hypothesis that exposure to air pollution may contribute to diabetes aetiology through inflammatory pathways. Since we have analysed two C/G polymorphisms located in the promoter region of *IL6* in our study, a potential mechanism of action could be related to changes in DNA methylation at these sites, affecting *IL6* gene expression. Air pollution exposure was positively associated with methylation of *IL6* in elderly men \[[@CR46]\]. Hypomethylation of *IL6* was associated with raised levels of serum IL-6 in patients with rheumatoid arthritis \[[@CR47]\], and with body weight among diabetes patients \[[@CR48]\]. In contrast, increased methylation of *IL6* was associated with risk of obesity \[[@CR49]\] and body weight among patients without diabetes \[[@CR48]\]. Furthermore there is suggestive evidence on a potential link between epigenetic changes at inflammatory genes (including *IL6*) and diabetes \[[@CR50], [@CR51]\]. While the evidence supports a role of *IL6* methylation with regard to both, air pollution and diabetes, the relevance of hyper- versus hypomethylation and the association with the *IL6* SNPs studied here needs further clarification.

Our study has major strengths. It provides first evidence to our knowledge on gene-air pollution interactions on diabetes risk. It derives from the large database of the population-based SAPALDIA cohort, with well characterized phenotypes, genotypes and lifestyle characteristics. Our air pollution estimates were assigned to participants' residences and derived from validated models which have been applied to other studies. \[[@CR33]\] By taking into account residential histories of participants, we could compute individual estimates of long-term exposure to air pollution, which is a crucial in understanding disease development and progression attributable to air pollution. We minimized outcome misclassification by identifying undiagnosed diabetes cases through additional blood tests.

Our study also has limitations. It has a cross-sectional design hence we cannot infer causality of observed associations. We tried to improve this by estimating air pollution exposure in the ten years prior to the survey where diabetes was assessed. In addition, an exploratory analysis excluding 17 diabetes cases who reported to have started using diabetes medication before 1991 gave very similar results. We could not differentiate T1D from T2D cases and therefore have misclassified a few cases (on the average \<10 % as T2D instead of T1D). \[[@CR31]\].

One of our functional SNPs of interest, *IL6* -572G \> C, was not in HWE (Table [1](#Tab1){ref-type="table"}). SNPs may deviate from HWE due to genotyping error, population stratification or population selection \[[@CR52], [@CR53]\]. Therefore, we assessed quality control by genotyping a subsample of our participants using an alternative genotyping array. There was no indication of genotyping errors since both SNPs had a perfect correlation between the two genotyping rounds. Also, we adjusted for population stratification in our study population using genome-wide principal components. It has been shown that SNPs may still deviate from HWE despite controlling for the afore-mentioned reasons \[[@CR53]\]. It is also important to note that *IL6* -572G \> C was not in HWE in a study linking it to T2D in Europeans \[[@CR38]\] and the minor alleles were similarly distributed between the reference study (MAF = 5 %) and our study (MAF = 7 %). Furthermore, the genotype frequencies were also similarly distributed \[Diabetes cases- GG: 90.6 %, GC: 9 %, CC: 0.4 %; No diabetes - GG: 86.7 %, GC: 12.6 %, CC: 0.7 % vs. Table [1](#Tab1){ref-type="table"}). We additionally assessed public databases to identify any potential interference on our PCR probe by nearby SNPs but found no evidence for such. We did not measure plasma IL-6 concentrations in our participants due to lack of funds, precluding our assessment of association between candidate SNPs and serum IL-6 levels, but there was a positive correlation between both SNPs and mean high-sensitivity C-reactive proteins (hs-CRP) measured at this first follow-up (*IL6* -572G \> C-CC: 1.28 g/l, GC: 1.45 g/l, GG: 1.58 g/l and *IL6* -174G \> C-CC: 1.58 g/l; GC: 1.53 g/l; GG: 1.60 g/l). The larger differences in hs-CRP levels associated with *IL6* -572G \> C agrees with its larger interaction effect. Lastly, our study had sample size limitations, especially among the CC genotype carriers of *IL6* -572G \> C, limiting the statistical power to detect more associations. Despite this, we made some statistically significant observations.

Conclusions {#Sec10}
===========

Our findings suggest that homozygous carriers of the common pro-inflammatory major 'G' allele of *IL6* -572G \> C polymorphism may be more susceptible to the diabetogenic effects of particulate matter, supporting the relevance of inflammatory pathways in the relationship between air pollution and diabetes. If confirmed, our results are of high public health relevance considering the ubiquity of the major G alleles, which put a substantial proportion of the population at risk for the development of diabetes as a result of exposure to air pollution. Our results therefore call for replication by other longitudinal population-based studies with adequate air pollution, genotype and diabetes information.

Additional file {#Sec12}
===============

Additional file 1: Table S1.Characteristics of included and excluded participants. **Table S2.** Association between functional *IL6* polymorphisms and diabetes. (DOCX 27 kb)

BMI

:   body mass index

DNA

:   Deoxyribonucleic acid

EDTA

:   ethylenediaminetetraacetic acid

HbA1C

:   Glycosylated haemoglobin

hs-CRP

:   high-sensitivity C-reactive proteins

HWE

:   Hardy-Weinberg equilibrium

*IL6*

:   Interleukin-6 gene

IL-6

:   Interleukin-6 cytokine

NO~2~

:   nitrogen dioxide

PM~10~

:   Particulate matter with diameter less than 10 microns

SAPALDIA

:   Swiss cohort study on air pollution and lung and heart diseases in adults

SNP

:   single nucleotide polymorphism

T1D

:   Type 1 diabetes

T2D

:   Type 2 diabetes.
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